Deutsche Bank Lowers Kenvue (KVUE) PT to $18, Keeps a Hold Rating

Group 1 - Kenvue Inc. (NYSE:KVUE) is considered a stock with significant upside potential despite recent price target reductions by major banks [1][2] - Deutsche Bank lowered its price target for Kenvue to $18 from $20 while maintaining a Hold rating [1][2] - JPMorgan also reduced its price target for Kenvue to $21 from $24, keeping an Overweight rating, citing a weak outlook for large-cap companies in the household and personal care sector [1][2] Group 2 - The consumer health company operates in multiple regions including the US, Europe, the Middle East, Africa, Asia-Pacific, and Latin America [3] - Kenvue's business segments include Self Care, Skin Health & Beauty, and Essential Health [3]